Skip Navigation
Search Menu
The Sidney Kimmel Comprehensive Cancer Center

In This Section      
 

Targeted Therapy for Lung Cancer

Targeted cancer therapy uses drugs to specifically targets lung tumor characteristics either specific gene changes or through one’s own immune system. This helps to stop the growth and spread of cancer by identifying and attacking cancer cells directly, while preserving normal cells.

Targeted cancer therapies offered at Johns Hopkins include:

  • Immunotherapy: Cancer immunotherapy trains the body’s immune system to recognize and destroy cancer cells, possibly resulting in longer-lasting remissions. It also produces fewer side effects. 
  • Epigenetic therapy slows or stops the growth of tumors by switching on certain genes to fight cancer cells, leading to better outcomes with treatment. 
  • Molecular targeted therapy, also known as tyrosine kinase inhibitors (TKIs), slows or stops the growth of tumors by directly acting on the abnormal cancer cell caused by specific gene mutations.

We continue to advance developments in targeted cancer therapies in our research and clinical trials.